These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2691695)

  • 1. Pathogenesis of atherosclerosis and its complications: effects of antihypertensive drugs.
    Spence JD
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():63-8. PubMed ID: 2691695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and atherosclerosis: effects of antihypertensive drugs on arterial flow patterns.
    Spence JD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S112-5; discussion S116. PubMed ID: 2481160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive drugs on atherogenic factors: possible importance of drug selection in prevention of atherosclerosis.
    Spence JD
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S121-5. PubMed ID: 2409360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral consequences of hypertension: where do they lead?
    Spence JD
    J Hypertens Suppl; 1996 Dec; 14(5):S139-45. PubMed ID: 9120671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiatherosclerotic and vasculoprotective effects of calcium antagonists: clinical implications.
    Ram CV
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():35-9. PubMed ID: 2090836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-atherosclerotic action of hypotensive drugs].
    Gmiński J; Stajszczyk M
    Wiad Lek; 1996; 49(7-12):182-98. PubMed ID: 9245114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension, antihypertensive drugs, and atherogenesis. Mechanisms and clinical implications.
    Chobanian AV
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):148S-157S. PubMed ID: 2878982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
    Leonetti G
    Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and atherosclerosis.
    Ram CV
    Prim Care; 1991 Sep; 18(3):559-75. PubMed ID: 1946788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic atherosclerosis in hypertensive rabbits treated with anti-hypertensive agents having different effects on arterial flow disturbances. 1. Extent of surface involvement.
    Spence JD; Perkins DG; Kline RL; Haust MD
    Paroi Arterielle; 1981; 7(4):177-87. PubMed ID: 7347391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiatherosclerotic effects of antihypertensive drugs].
    Galesić K
    Lijec Vjesn; 2006; 128(11-12):341-5. PubMed ID: 17212195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antihypertensive agents on serum lipids and lipoproteins.
    Lardinois CK; Neuman SL
    Arch Intern Med; 1988 Jun; 148(6):1280-8. PubMed ID: 2897834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and vascular disease.
    Doyle AE
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S7-10. PubMed ID: 1381798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.